{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "The “Break Up Big Medicine Act”: Potential Impacts for Healthcare Investors",
    "url": "https://www.lexblog.com/2026/02/26/__trashed-2/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-8G4JR04C",
        "url": "https://www.lexblog.com/lib/8G4JR04C/"
    },
    "datePublished": "2026-02-26T15:33:24-05:00",
    "dateModified": "2026-02-26T15:52:02-05:00",
    "author": {
        "@type": "Person",
        "name": "Ashley Seibler, Jason Madden"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Proskauer Rose LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Care Law Brief",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.healthcarelawbrief.com/?p=2793",
    "sourceStability": "may-move"
}